graphy were 88.9%, 12.0%, 57.4%, 59.3%, and 42.9% and those for additional ultrasound were 94.4%, 64.0%, 82.0%, 79.1%, and 88.9%, respectively. The differences of specificity and accuracy were statistically significant (p=0.0003). On the ROC analysis, ACU were significantly different between mammography (AUC=0.586, 95% CI=0.453-0.711) and ultrasound (AUC=0.823, 95% CI=0.704-0.909) (p=0.003). Clustered calcifications with associated masses or ductal changes on additional breast ultrasound had high frequency of malignancies, 79% or 73%. In addition, 87% of malignant masses were invasive carcinomas and 45% of malignant ductal changes were ductal carcinomas in situ. Conclusion: Additional breast ultrasound examinations for the lesions with clustered calcifications on mammography can improve the diagnostic performance and significantly contribute to the specificity and accuracy of a diagnosis of breast carcinoma. In addition, the ultrasound features may predict the pathologic findings such as benignity or malignancy and invasive carcinoma or ductal carcinoma in situ.
INTRODUCTION
Mammographic breast screening programs have increased the detection of early nonpalpable breast carcinoma and reduced the mortality rate of breast carcinoma. (1) Moreover, calcifications may be the most reliable mammographic feature in early nonpalpable breast carcinoma, and are present in 30-50% of breast carcinomas. (2, 3) Mammography is highly sensitive at evaluating breast calcifications, but its specificity for a diagnosis of breast carcinoma is limited. Only 20-35% of cases with calcifications are proven to be carcinomas after wire localization and excisional biopsy.(4-6) Therefore, unnecessary biopsies are performed and these cause worry and increase medical costs.
It has been reported that high-resolution ultrasound (US) can improve the detection and characterization of
Purpose: We wanted to determine whether additional breast ultrasound examinations are needed for patients who have clustered calcifications found by mammography for the detection of breast carcinomas. Methods: We performed targeted ultrasound examinations in 125 consecutive patients who had clustered calcifications found by mammography. Fortyeight pathologically proven patients with 61 breast lesions were included in this study (26 invasive carcinomas, 10 ductal carcinomas in situ and 25 benign diseases). Two breast radiologists evaluated the mammography and the ultrasound findings and they graded the probability of malignancy by consensus as follows: definitely benign 1, probably benign 2, probably malignant 3, and definitely malignant 4. The diagnostic performance values, including the sensitivity, specificity, accuracy, positive predictive value and negative predictive value, for mammography and additional ultrasound were compared using McNemar's test and receiver operating characteristic (ROC) analysis. On the ROC analysis, areas under the ROC curves (AUC) and 95% confidence intervals (CI) were obtained. Results: The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value for making the diagnosis of breast carcinoma by mammo-breast calcifications. (7, 8) On breast US, calcifications are visualized as echogenic dots. However, US has low sensitivity as a primary imaging modality for the detection of calcifications, which remains its major limitation. (9) Furthermore, when calcifications are located inside echogenic, fibroglandular breast tissues, they may not be depicted by US because it is difficult to differentiate them from echogenic interfaces among tissues. However, US can detect associated masses or ductal changes in patients with calcifications, thus, US might be a feasible secondline additional diagnostic tool.
The purpose of this study was to determine whether additional US is needed in patients with clustered calcifications by mammography to improve diagnostic accuracy for breast carcinoma. patients with 63 lesions were obtained tissue diagnosis by US-guided core needle biopsy (n=35), mammotome biopsy (n=5), or surgical excision (n=23) and two lesions that did not contain calcifications with specimens were excluded to eliminate the possibility of inadequate sampling. Accordingly, pathologically proven 48 patients with 61 lesions were included in this study. Specimen radiographs were obtained of all 61 lesions to confirm whether specimens contained calcifications. After confirming the presence of calcifications, specimens were sent for pathologic examination. Hematoxylin and Eosin-stained (H& E) sections of all breast lesions were examined by a boardcertified pathologist. Table 1 demonstrates patients and lesions characteristics. All patients were women and mean age was 44 yr.
METHODS

Patients
The size of lesions was obtained by using mammography and the maximum distance of calcifications was measured.
By pathologic examination 36 (59%) of the 61 breast lesions were malignant and the 36 malignant lesions were treated by mastectomy (n=16) or breast conserving surgery (n=20).
When we correlated with clinical symptoms and pathologic findings, all 15 palpable masses were malignant; 13 invasive ductal carcinomas and 2 ductal carcinoma in situ (DCIS) cases. Of the two lesions with a nipple discharge, one was DCIS and the other was an intraductal papilloma.
In terms of the 44 asymptomatic lesions, 13 were invasive ductal carcinomas, 7 were DCIS cases, and the remaining 24 were benign diseases.
Mammography and US examinations
Mammograms were obtained either using a film-screen mammography system (Bennett Contour; Bennett Co., New York, USA) or a digital mammography system (Selenia IV; Lorad, Bedford, USA). In all 48 patients, standard craniocaudal and mediolateral oblique views were obtained followed by spot compression or magnification views of areas containing calcifications. Mammography images 
RESULTS
Mammography
Breast compositions for the 61 lesions were; almost entirely fat (n=3), scattered fibroglandular densities (n=15), heterogeneously dense (n=11), and extremely dense (n= 32). Calcification morphologies were; lucent-centered in (Figures 1, 2 ).
In these 23 malignant calcifications with associated mass- The two lesions categorized as microcalcifications within normal ducts because ductal diameters were normal and no ductal wall thickening was evident were benign.
In 14 clustered calcifications without detectable breast lesions on US, two lesions were malignancies, DCIS cases (Table 3 ). These two lesions were shown as amorphous calcifications (grade 3) and punctuate calcifications (grade 2) on mammography.
The diagnostic performances of mammography and US
The sensitivity, specificity, accuracy, PPV and NPV for a diagnosis of breast carcinoma by mammography were 88.9%, 12.0%, 57.4%, 59.3%, and 42.9%, respectively, and those by additional US were 94.4%, 64.0%, 82.0%, 79.1%, and 88.9%, respectively. All diagnostic performance values of additional US were higher than those of mammography alone. Specificity and accuracy values of additional US were significantly higher than those of mammography (p=0.0003) ( Table 5 ). Figure 5 shows the ROC analysis for diagnostic performance of mammography Table 3 . Correlation between grades of probability of malignancy using mammography or additional US and pathologic diagnoses Thus, we studied consecutive pathologically verified clustered calcifications by mammography.
In this study, we graded probability of malignancy using 
CONCLUSION
In conclusion, additional breast US can improve diagnostic performance for lesions with clustered calcifications on mammography, and that it can substantially increase diagnostic specificity and accuracy for diagnosis of breast carcinoma. In addition, breast US can detect associated masses or ductal changes, which are associated with higher malignancy rate. The study demonstrates the majority of lesions with associated malignant masses were invasive carcinomas and half of the lesions with associated malignant ductal changes were DCIS. Accordingly, additional breast US may be helpful for predicting malignant tumor type.
